Organization: Genome Quebec

CIHR spearheads national epigenetics consortium

A select group of Canadian and Japanese stakeholders have pooled $41 million in funding over five years to launch an epigenetics research consortium to examine how environmental factors can alter the expression of DNA. The Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC) will receive $28.5 million from the Canadian Institutes of Health Research, augmented…

Ontario-Quebec life science collaboration focus of meeting

Efforts to establish an Ontario-Quebec Life Sciences Corridor accelerated with a partnering event in which more than 80 participants participated in 130 individual meetings designed to foster collaboration between scientists and industry. The Toronto event was planned by the Ontario Genomics Institute, Genome Québec and the Quebec Consortium for Drug Discovery. Project pitches and one-to-one…

Top Genome Quebec executives resign

The two top positions at Genome Quebec are vacant following the resignations of president and CEO Paul L’Archeveque and VP scientific affairs Carole Jabet. The February 26 announcement by board chair Jean-Marc Proulx said the resignations were effective immediately and that Proulx would assume the positions until replacement were found. He has subsequently been named…

RNomics platform opens at Univ of Sherbrooke

Génome Québec has established its third technology platform and the first outside the Montreal region. The Génome Québec and Université de Sherbrooke RNomics Platform is being launched with $2.2 million in funding from the two partners and is affiliated with the Univ of Sherbrooke’s Functional Genomics Laboratory, situated in the faculty of medicine and health…

Genome Quebec launches new competition

Genome Québec is aiming to funnel $30 million into applied genomics/proteomics research in the province with PRIVAC, a new $10-million competition for mixed academic/private initiatives. Successful projects must secure one third of their financing from a private company and a minimum investment of $2 million is required. The objective is to fund between six and…

Canada to participate in HapMap project

Canadian researchers will be participating in a $100-million project to speed the discovery of genes related to common diseases such as asthma, cancer, diabetes and heart disease. The International HapMap Project is a public-private, international consortium involving researchers from Canada (led Dr Thomas Hudson of McGill Univ), the US, Japan, China and the UK. Funding…